Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes-Reference-Cited by-同舟云学术

Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes

Published:2021-06 Issue: Volume:Volume 14 Page:675-683
ISSN:1178-6965
Container-title:Journal of Asthma and Allergy
language:en
Short-container-title:JAA

Author:

Prazma Charlene M,Idzko Marco,Douglass Jo Anne,Bourdin Arnaud^ORCID,Mallett Stephen,Albers Frank C^ORCID,Yancey Steven W

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy

Reference31 articles.

1. Global Initiative for Asthma. Available from: Global Strategy for Asthma Management and Prevention. https://ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_04-1-wms.pdf. Accessed January 2, 2020.

2. Severe asthma: from characteristics to phenotypes to endotypes

3. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

4. Overlap of atopic, eosinophilic, and TH2-high asthma phenotypes in a general population with current asthma

5. The airway epithelium in asthma

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Effectiveness of Mepolizumab in Patients with Allergic and Non-Allergic Asthma;Journal of Asthma and Allergy;2024-03

2. Update of systemic treatments in severe/recalcitrant atopic dermatitis: Consensus document of the KAAACI working group on atopic dermatitis;Allergy, Asthma & Respiratory Disease;2024

3. Tezepelumab in patients with allergic and eosinophilic asthma;Allergy;2023-12-26

4. Efficacy of Biologics in Patients with Allergic Severe Asthma, Overall and by Blood Eosinophil Count: A Literature Review;Advances in Therapy;2023-09-12

5. Physiopathologie de l’asthme sévère : quelles cibles moléculaires pour les biothérapies ?;Bulletin de l'Académie Nationale de Médecine;2023-05